Condensed Consolidated Statements of Operations (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Revenue
Product sales	$ 221,080
Cost of product sales	70,218	19,348
Gross profit from product sales	150,862	(19,348)
Other Revenue
Retained royalties	2,604	13,376
Other income	3,821	48,679
Total other revenue	6,425	62,055
Expenses
Selling expenses	71,994	68,175
Personnel and consulting expenses	395,023	341,007
General and administrative expenses	193,721	400,759
Interest expense	104,786	32,767
Loss on settlement of note and warrant	132,301
Unrealized gain on derivative instruments	(14,232)	(18,167)
Total Expenses	883,593	824,541
Loss before income taxes	(726,306)	(781,834)
Provision (benefit) for income taxes
Net loss	$ (726,306)	$ (781,834)
Basic loss per share	$ (0.04)	$ (0.05)
Basic weighted average number of common shares outstanding	20,036,240	15,588,693
Diluted loss per share	$ (0.04)	$ (0.05)
Diluted weighted average number of common shares outstanding:	20,036,240	15,588,693